Regulatory
Morgan Stanley, through its subsidiary Morgan Stanley — Morgan Stanley & Company LLC, has increased its voting rights in STRATEC SE, a German medical technology company, crossing the 10% threshold on 15 July 2026. The…
Impact: Janus Henderson Investors reduced its stake in STRATEC SE to zero, following a go-private transaction and group restructuring. This represents a complete exit from the company, which may be seen as a slight negative signal but is part of a broader restructuring.
Jul 08, 2026 · 20 articles